ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,638Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 288

$954K Total Retail Price of All Prescriptions

Rank: 5 out of 288

646 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 646 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 646 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 19,341 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 1,097 1,017 1 1
FUROSEMIDE 864 817 2 5
ISOSORBIDE MONONITRATE ER 773 766 3 35
OMEPRAZOLE 732 686 4 3
LISINOPRIL 723 676 5 4
ATORVASTATIN CALCIUM 695 678 6 14
METOPROLOL SUCCINATE 685 663 7 15
POTASSIUM CHLORIDE 605 547 8 11
AMLODIPINE BESYLATE 598 567 9 6
LEVOTHYROXINE SODIUM 589 530 10 2
METFORMIN HCL 483 449 11 12
ATENOLOL 447 414 12 10
WARFARIN SODIUM 436 419 13 9
SERTRALINE HCL 427 416 14 25
METOPROLOL TARTRATE 417 402 15 8
HYDROCHLOROTHIAZIDE 385 377 16 13
LOSARTAN POTASSIUM 319 319 17 16
HYDROCODONE-ACETAMINOPHEN 256 223 S3 18 7
SPIRONOLACTONE 213 205 19 36
DIGOXIN 213 209 19 51
ALLOPURINOL 186 165 21 23
GLIMEPIRIDE 184 177 22 32
PRAVASTATIN SODIUM 170 165 23 21
ENALAPRIL MALEATE 168 156 24 40
CLOPIDOGREL 163 156 25 47
ALENDRONATE SODIUM 162 157 26 20
LOSARTAN-HYDROCHLOROTHIAZIDE 161 148 27 55
DIOVAN 161 161 27 53
GABAPENTIN 155 134 29 17
KLOR-CON 10 153 152 30 66
RAMIPRIL 146 135 31 101
TRAMADOL HCL 141 139 32 19
LIPITOR 133 120 33 107
ZOLPIDEM TARTRATE 131 118 34 22
FAMOTIDINE 131 130 34 68
PLAVIX 129 129 36 71
GLIPIZIDE 125 124 37 56
TAMSULOSIN HCL 121 110 38 24
DONEPEZIL HCL 120 120 39 29
NEXIUM 114 99 40 43
PREDNISONE 108 105 41 30
CARVEDILOL 107 94 42 27
GEMFIBROZIL 104 102 43 77
JANUVIA 103 103 44 88
TRAZODONE HCL 98 79 45 37
TRIAMTERENE-HCTZ 95 95 46 28
PROPRANOLOL HCL 94 82 47 90
LEVOFLOXACIN 88 82 48 80
SYNTHROID 85 85 49 63
ISOSORBIDE DINITRATE 79 72 50 302
KLOR-CON M20 77 77 51 110
CRESTOR 76 76 52 26
LANTUS SOLOSTAR 73 65 53 81
PROAIR HFA 73 56 53 45
LEVEMIR 71 71 55 194
PANTOPRAZOLE SODIUM 70 65 56 42
OXYBUTYNIN CHLORIDE ER 70 65 56 116
AMITRIPTYLINE HCL 69 59 R 58 65
CELEBREX 68 68 59 84
AZITHROMYCIN 67 61 60 49
NAMENDA 66 66 61 39
DIOVAN HCT 66 66 61 112
VENLAFAXINE HCL ER 64 39 63 94
ADVAIR DISKUS 64 63 63 50
LEVEMIR FLEXPEN 61 48 65 187
NITROSTAT 59 57 66 156
RANITIDINE HCL 59 38 66 33
CYMBALTA 59 59 66 67
AMLODIPINE BESYLATE-BENAZEPRIL 59 59 66 89
LORAZEPAM 58 58 70 260
KLOR-CON M10 58 53 70 175
MORPHINE SULFATE 58 53 S2 70 240
PEN NEEDLE 57 50 73 100
INSULIN SYRINGE 56 54 74 79
SPIRIVA 55 55 75 48
CLONIDINE HCL 54 52 76 70
VESICARE 54 43 76 129
TOPROL XL 54 54 76 340
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 52 79 113
PHENYTOIN SODIUM EXTENDED 51 41 80 167
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.